Ross Clark Ross Clark

The straight dope | 21 June 2018

The Billy Caldwell case is being exploited by the pro-legalisation lobby for its own ends

issue 23 June 2018

Was there ever a more fatuous contribution to a political debate than Lord Hague following up the case of 12-year-old Billy Caldwell — the boy whose mother says he needs cannabis oil to control his epilepsy — with a demand for recreational cannabis to be legalised? But the former foreign secretary has done us a favour of sorts. He has inadvertently explained why Billy Caldwell has become such a cause célèbre over the past few days: the drug-legalisation lobby has cottoned on to his huge propaganda potential.

The reason why cannabis oil is not licensed for use as a treatment for epilepsy in Britain has nothing to do with the prohibition of cannabis as a recreational drug. Opiates are banned as recreational drugs but that does not prevent their routine use as a painkiller in controlled doses. Moreover, there is a cannabis-derived medicine, Sativex, which is licensed in Britain for pain relief in patients with multiple sclerosis.

Comments

Join the debate for just $5 for 3 months

Be part of the conversation with other Spectator readers by getting your first three months for $5.

Already a subscriber? Log in